Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Post by u2bobon Dec 01, 2017 11:39am
93 Views
Post# 27072455

Future Looks Bright...

Future Looks Bright...Busy last few weeks for ADK presented to Quebec Minster of Health ...with money to be set aside next fiscal year for screening..Now we just finished up in San Palo Brazil... where we had their Minster of Health as a speaker... we are getting the word out to the right people in government positions who decide the future spending in Healthcare...next stop UAE for IDF Presentation in Abu Dhabi ...

 Dr Iyari Sanchez Diaz will be presenting the results of last year screening campaign of more than 80,000 diabetic patients using Diagnos technology at the IDF ...



althcare & Life Sciences

FT Latin America Healthcare & Life Sciences Summit

Riding the Next Wave of Industry Transformation

So Paulo | 
Speakers include:
 Ricardo Barros

Ricardo Barros

Brazil

Rifat Atun

Rifat Atun

Harvard University

Carlos Marinelli

Carlos Marinelli

Grupo Fleury

OVERVIEW

Despite the challenging economic and political backdrop of recent years, Latin America remains a market of key interest to healthcare and life science investors, with significant opportunities emerging across the healthcare spectrum both in and beyond the established first tier markets of the region. A growing recognition of the role that value based care, digital technologies and consolidation across a still largely fragmented industry can play in managing costs and driving efficiencies are reshaping the healthcare and life sciences sector -with important implications for providers, investors and patients. Yet opportunity may yet be tempered by continuing uncertainty regarding the economy, and the impact of the new US administration for trade and investment in the region. How will the future unfold?

The FT Latin America Healthcare and Life Sciences Summit, which this year takes place in Brazil, the region’s market leader , will provide a timely opportunity to examine and discuss the major trends shaping the public and private healthcare and life sciences industries of the region, as well as the emerging opportunities and challenges for investors.

Viso geral

Apesar do cenrio econmico e poltico desafiador dos ltimos anos, a Amrica Latina permanece um mercado de importante interesse para investidores em cuidados de sade e cincias biolgicas, com oportunidades significativas surgindo por todo o espectro de cuidados de sade, dentro e alm dos mercados de primeiro nvel estabelecidos na regio. Um crescente reconhecimento do papel que cuidado com base em valor, tecnologias digitais e consolidao num setor ainda grandemente fragmentado podem desempenhar na gesto de custos e para impulsionar eficincias est transformando o setor de cincias biolgicas e cuidados de sade - com importantes implicaes para provedores, investidores e pacientes. Mesmo assim, a oportunidade ainda pode ser moderada devido constante incerteza em relao economia e o impacto da nova administrao dos EUA em termos de comrcio e investimentos na regio. Como ser o futuro de cuidados de sade na regio?

Encontro da FT sobre Cuidados de sade e Cincias biolgicas na Amrica Latina,que este ano ocorrer no Brasil, lder do mercado na regio, oferecer uma oportunidade especfica para analisar e discutir as principais tendncias que esto moldando os setores de cincias biolgicas e cuidados de sade do setor pblico e privado da regio, bem como visualizar oportunidades e desafios emergentes para investidores.

Simultaneous translations will be provided at the summit. 

SPEAKERS (29)

 Ricardo Barros

Ricardo Barros

Minister of Health
Brazil
Rifat Atun

Rifat Atun

Professor of Global Health Systems
Harvard University
Carlos Marinelli

Carlos Marinelli

CEO
Grupo Fleury

CHAIR AND MODERATOR (3)

David Crow

David Crow

Senior US Business Correspondent
Financial Times
Joseph Leahy

Joseph Leahy

Brazil Bureau Chief
Financial Times

Greg Reh

Global Life Sciences & Health Care Industry Leader
Deloitte



 


 

IDF Congress 2017

Under the Patronage of His Highness Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces


The global diabetes community will again unite at the IDF 2017 Congress in Abu Dhabi, UAE, on 4-8 December 2017. The event will include more than 200 speakers, both world-renowned and newcomers, 230 national diabetes associations from 170 countries and high level participation from the Health Authority Abu Dhabi (HAAD) and other health organisations.

IDF 2017 transport information for delegates.

Online registration closed on 13 November 2017. We invite you to register for the IDF Congress 2017 onsite.

My congress profile

My IDF Congress Profile is the tool to plan your congress experience. With your congress profile you can access congress information including the scientific programme.

Go to my congress profile

Scientific programme

The scientific programme provides the latest developments in diabetes clinical practice, management, education, prevalence and public health issues. The broad nature of the programme is invaluable for all professionals in the field of diabetes, from clinicians and physicians to educators, public health specialist, epidemiologists, as well as policy makers and advocates. With over 160 hours of sessions, 300 top-level speakers, 1000 posters and an estimated 21 CME credits, the programme aims to provide the delegate with an invaluable learning experience through varied and innovative sessions.

Go to the scientific programme

The easiest way to plan your congress experience is through the IDF 2017 mobile app. The app contains all the useful information you will need before and during the congress. Full session details, speaker information, maps and practical information are at your fingertips with this great tool.

Available for Android and iOS.

© 2017 International Diabetes Federation 

Bullboard Posts